By Jeff Overley ( August 25, 2021, 10:34 PM EDT) -- A New York judge made it "abundantly clear" Wednesday that he may severely punish Endo Pharmaceuticals for discovery failings in the Empire State's opioid trial, ruling that the drugmaker disobeyed a stopgap remedy and observing that its Arnold & Porter lawyers were deemed dishonest in another opioid case....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.